The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers
Clinical trial NCT01999114 · COMPLETED
Trial details
- NCT number
- NCT01999114
- Sponsor
- Purdue Pharma LP
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.